Inotiv, Inc. (NOTV)
NASDAQ: NOTV · Real-Time Price · USD
0.8077
-0.0712 (-8.10%)
At close: Dec 5, 2025, 4:00 PM EST
0.8180
+0.0103 (1.28%)
After-hours: Dec 5, 2025, 7:41 PM EST
Inotiv Market Cap
Inotiv has a market cap or net worth of $27.75 million as of December 5, 2025. Its market cap has decreased by -61.78% in one year.
Market Cap
27.75M
Enterprise Value
462.37M
1-Year Change
-61.78%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since December 1, 1998, Inotiv's market cap has increased from $20.80M to $27.75M, an increase of 33.42%. That is a compound annual growth rate of 1.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 27.80M | -74.19% |
| Dec 31, 2024 | 107.70M | 13.73% |
| Dec 29, 2023 | 94.70M | -25.08% |
| Dec 30, 2022 | 126.40M | -87.62% |
| Dec 31, 2021 | 1.02B | 650.66% |
| Dec 31, 2020 | 136.00M | 161.54% |
| Dec 31, 2019 | 52.00M | 300.00% |
| Dec 31, 2018 | 13.00M | -35.64% |
| Dec 29, 2017 | 20.20M | 225.81% |
| Dec 30, 2016 | 6.20M | -49.59% |
| Dec 31, 2015 | 12.30M | -30.11% |
| Dec 31, 2014 | 17.60M | -15.79% |
| Dec 31, 2013 | 20.90M | 100.96% |
| Dec 31, 2012 | 10.40M | 19.54% |
| Dec 30, 2011 | 8.70M | -29.84% |
| Dec 31, 2010 | 12.40M | 143.14% |
| Dec 31, 2009 | 5.10M | -23.88% |
| Dec 31, 2008 | 6.70M | -84.27% |
| Dec 31, 2007 | 42.60M | 58.36% |
| Dec 29, 2006 | 26.90M | -1.82% |
| Dec 30, 2005 | 27.40M | 12.76% |
| Dec 31, 2004 | 24.30M | 34.25% |
| Dec 31, 2003 | 18.10M | 44.80% |
| Dec 31, 2002 | 12.50M | -60.94% |
| Dec 31, 2001 | 32.00M | 201.89% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |